Diagnostic Kits/Patents limit medical potential of sequencing

From Commons Based Research
< Diagnostic Kits
Revision as of 15:42, 10 September 2009 by AClearwater (talk | contribs) (New page: *Merz, J.F., 2002 - This brief comment by Merz makes two important points. Quick and easy gene sequences will be limited because of patents and licensing. First, some patent holders wi...)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
  • Merz, J.F., 2002 - This brief comment by Merz makes two important points. Quick and easy gene sequences will be limited because of patents and licensing. First, some patent holders will not license their patents which will prevent a comprehensive test form being developed. Second, given those that do license the amount of licenses required and the stacked royalty payments will make the test prohibitively expensive.
Retrieved from "http://cyber.harvard.edu/commonsbasedresearch/?title=Diagnostic_Kits/Patents_limit_medical_potential_of_sequencing&oldid=3994"